Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intraperitoneal paclitaxel for primary malignant peritoneal mesothelioma
NL-OMON56619Phase 2Recruiting
- Sponsor
- Erasmus MC
- Start
- Mar 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of paclitaxel in peritoneal mesothelioma, sponsored by Erasmus MC. Started Mar 2022; status: recruiting.
02
Drugs
paclitaxel
03
Conditions
peritoneal mesothelioma
Beyond the preview
Go deeper on NL-OMON56619.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON56619.